Dhan Chand, Vice President of Research at Agenus, shared a post on LinkedIn:
“BOT + BAL is redefining the treatment paradigm in colorectal cancer, with unprecedented responses and no recurrences in the neoadjuvant setting.
This approach is turning ‘cold’ tumors ‘hot’.
For patients, this means a real chance at complete tumor clearance and new hope for a cancer-free future.”
